Senators Call on Abbott to Turn Over Info and Documents Regarding Infant Formula Recall

In a letter to Abbott last week, Sens. Patty Murray and Bob Casey said they are concerned that the company received complaints as early as September 2021 but only took public action last week.

U.S. Senator Patty Murray
U.S. Senator Patty Murray
United States Senate

WASHINGTON, D.C. — In a letter to Abbott board chairman and CEO Robert Ford last week, Sens. Patty Murray (D-Wash.) and Bob Casey (D-Pa.) requested the company provide more info and documentation regarding its voluntary recall of infant formula on Feb. 17. 

"Formula is a critical source of nutrition for newborns and infants," the letter read. "It is particularly disappointing that you would describe the past year as “outstanding” for Abbott when there are such serious outstanding safety concerns. 6 We want to ensure that no corners are being cut when it comes to infant and newborn safety. We demand assurances that your company is taking every effort to work with its state, federal, and global partners to protect any additional children from illness and to ensure parents and caregivers have the information they need—and we remain deeply troubled that this highly vulnerable population was ever placed at risk."

Citing a Politico story, the letter said that, "According to press reports, the Minnesota Department of Health began investigating a case of an infant infected with Cronobacter sakazakii in September 2021."

The letter asked for the requested documents to turned over by March 10. Read the letter here.

No more results found.
No more results found.